- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05779787
COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY) (COMFORT)
COronary Re-EngageMent aFter RandOm NavitoR Alignment (COMFORT STUDY)
Whereas PCI before TAVR was previously recommended despite its uncertain prognostic role, recent data underline the possibility of a postponed coronary intervention using a commissural alignment technique. This approach allows easy coronary re-engagement through the valve stent frame with a trade off paid of procedure complexity.
Considering the prevalence of coronary artery disease (CAD) and the increasing percentage of younger patients treated with TAVI, investigate whether a simpler procedure with random implantation of Navitor valve is not inferior in terms of coronary re-access, is required The key point of the project will be the evaluation of the feasibility of coronary re-engagement after a Navitor valve randomly implanted.
Study Overview
Status
Intervention / Treatment
Detailed Description
Transcatheter Aortic Valve Implantation (TAVI) is recommended by European and American guidelines to treat patients with aortic stenosis regardless of procedural risk (1, 2). In the last decades the increasing percentage of younger patients treated with TAVI, reflect the extensive indications in lower risk setting, highlighting the importance of easy coronary re-engagement after valve implantation. Considering the prevalence and the progression of a pre-existing coronary artery disease (CAD), the timing of coronary intervention should be accurate selected (3) addressing the percentage of unplanned percutaneous coronary intervention (PCI) after TAVI (4). In fact, while PCI before TAVR was previously recommend despite the uncertain prognostic role (5), recent data remarks the possibility of a postponed coronary intervention using a commissural alignment technique (6) that allows a predictable stent frame position in the sinus of Valsalva (7). Moreover, following the emerging concept of easy re-access, only a few types of prostheses have been shown to have an high degree of stent position predictability after implantation, leading to a limited option in terms of prosthesis choice. Furthermore, to achieve the best results with commissural alignment technique, accurate procedure planning and operator's expertise are required in order to properly manage the valve specific orientation in the aorta with consequent increase in time, radiation and procedure complexity.
However, geometry of the stent frame (height and size) and the anatomical characteristics of patients have to be enlisted as contributory factors to difficult coronary re-engagement and need to be evaluate in order to establish the feasibility of the re-access after TAVR.
The investigators' findings could provide data regarding the non-inferiority rate of coronary cannulation after a simpler procedure with Navitor implantation without alignment technique. Due to these results, the valves portfolio available in patients with coronary artery disease that needed PCI after TAVR, could be larger and various allowing the best protheses choice according to the patient's anatomy and operator's expertise. Finally, knowing the predictors of difficult re-engagement for both types of valves, regardless of implantation technique, could be interesting for an even more valve tailored approach.
The purpose of this study is to investigate the feasibility of coronary re-engagement after randomly (not aligned) Navitor implantation, as already perform in current clinical practice, due to a lower predictable orientation of this type of valve.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Giuseooe Esposito, MD
- Phone Number: +393278393131
- Email: giuseppe.esposito@yahoo.com
Study Locations
-
-
Lombardia
-
MIlano, Lombardia, Italy, 20162
- Recruiting
- ASST GOM Niguarda
-
Contact:
- Giuseppe Esposito, MD
- Phone Number: +393278393131
- Email: giuseppe.esposito@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Patients to be included in this registry should have all the following criteria:
1. Severe, symptomatic aortic stenosis with an indication to TAVI
Exclusion criteria and definition
Patients excluded in this registry should have all the following criteria:
- Valve in Valve procedure
- Hemodynamical instability
- TAVR performed from other access (not femoral)
- No-CT Planned TAVR
- TAVR performed with Chimney Technique
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
TAVR performed with commissural alignment technique (Aligned Group)
Patients with severe aortic stenosis undergoing TAVR procedure performed with commissural alignment technique.
We consider in this groups only the Accurate and Accurate Neo 2 Valve which are the first choice due to the best stent frames position predictability with this technique
|
Investigate the feasibility of coronary re-engagement after commissural alignment technique in terms of success rate (%) and procedure complexity taking into account radiations, time and contrast used.
TAVR Random Feasibility comparison of coronary re-engagement between the randomly implanted Navitor valve (unaligned) and the others implanted with the commissural alignment technique in terms of success rate (%) and complexity of the procedure, taking into account radiation, time and contrast used
|
TAVR performed with random implantation of Navitor valve (Random Group)
Patients with severe aortic stenosis undergoing TAVR procedure performed with random implantation of Navitor Valve
|
Investigate the feasibility of coronary re-engagement after commissural alignment technique in terms of success rate (%) and procedure complexity taking into account radiations, time and contrast used.
TAVR Random Feasibility comparison of coronary re-engagement between the randomly implanted Navitor valve (unaligned) and the others implanted with the commissural alignment technique in terms of success rate (%) and complexity of the procedure, taking into account radiation, time and contrast used
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Coronary re-access after TAVR procedure
Time Frame: During procedure
|
Re-engagement of LMCA and RCA after valve implantation is defined as selective cannulation and subsequent selective angiography.
All others type of re-engagement will be classify as "non selective".
We will stratify also the modality of re-cannulation in relation to the position of the valves' stent struts as "above", "across" and "behind".
|
During procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Implant Time
Time Frame: During procedure
|
Total time required for valve implantation.
We count the time from the alignment in the aorta to the end of valve opening (Alignment Fluoroscopy time + Implantation Fluoroscopy time).
|
During procedure
|
Total Implant Fluoroscopy Time
Time Frame: During procedure
|
Total Fluoroscopy time required for valve implantation.
We count the time from the alignment in the aorta to the end of valve opening (Alignment time + Implantation time).
|
During procedure
|
Total Implant Radiations
Time Frame: During procedure
|
Total Radiations required for valve implantation.
We count the radiations used from the alignment in the aorta to the end of valve opening (Alignment time + Implantation time).
|
During procedure
|
Total Implant Contrast
Time Frame: During procedure
|
Total Contrast required for valve implantation
|
During procedure
|
Alignment Radiation
Time Frame: During procedure
|
Radiation required for commissural alignment
|
During procedure
|
Alignment Fluoroscopy Time
Time Frame: During procedure
|
Fluoroscopy time required for commissural alignment
|
During procedure
|
Implant Radiation
Time Frame: During procedure
|
Radiation required for valve implantation
|
During procedure
|
Implant Fluoroscopy Time
Time Frame: During procedure
|
Fluoroscopy time required for valve implantation
|
During procedure
|
Implant Contrast
Time Frame: During procedure
|
Contrast required for valve implantation
|
During procedure
|
Re-Engagement Radiation
Time Frame: During procedure
|
Radiation required for re-engagement
|
During procedure
|
Re-Engagement Fluoroscopy Time
Time Frame: During procedure
|
Fluoroscopy time required for coronary re-engagement
|
During procedure
|
Re-Engagement Contrast used
Time Frame: During procedure
|
Contrast required for coronary re-engagement
|
During procedure
|
Re-Engagement Time
Time Frame: During procedure
|
Time required for coronary re-engagement
|
During procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D001024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Valve Stenosis
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
The Medicines CompanyCompletedTranscatheter Aortic Valve Replacement | Aortic Valve Replacement | Severe Aortic StenosisNetherlands, Germany, United Kingdom, Canada, France, Italy, Switzerland
-
Anteris Technologies Ltd.Active, not recruitingAortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisGeorgia
-
Ningbo Jenscare Biotechnology Co., Ltd.UnknownAortic Regurgitation | Severe Aortic Stenosis
-
Edwards LifesciencesActive, not recruitingAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Edwards LifesciencesCompletedAortic Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Regurgitation, Aortic Valve | Aortic Valve IncompetenceUnited States
-
Sorin Group USA, Inc.TerminatedAortic Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Regurgitation, Aortic Valve | Aortic Valve IncompetenceUnited States
-
Hospices Civils de LyonRecruiting
-
BC Centre for Improved Cardiovascular HealthEdwards LifesciencesUnknownTranscatheter Aortic Valve Implantation | Severe Aortic StenosisCanada
-
Genesis Medtech CorporationRecruitingDiseases of Aortic Valve | Aortic Stenosis DiseaseChina
Clinical Trials on TAVR Aligned
-
Perth Hip and KneeSt John of God Private Hospital SubiacoRecruitingOsteoarthritis | Osteo Arthritis KneeAustralia
-
The Catholic University of KoreaUnknownKnee Osteoarthritis | Anatomically Aligned Total Knee Arthroplasty
-
VA Office of Research and DevelopmentCompletedSchizophrenia Spectrum & Other Psychotic DisordersUnited States
-
Abbott Medical DevicesCompletedAortic Valve StenosisGermany, Netherlands, Italy, Switzerland, Denmark
-
Edwards LifesciencesActive, not recruitingSymptomatic Severe Aortic StenosisUnited States
-
IRCCS Policlinico S. DonatoCompletedFailed Transcather Aortic ValveItaly
-
University of UlmCompletedPM Implantation After TAVRGermany
-
Michele De BonisCompletedAortic StenosisDenmark, Hungary, Italy
-
Edwards LifesciencesAmerican College of CardiologyCompletedCalcific Aortic Stenosis | Severe | SymptomaticUnited States
-
IRCCS Policlinico S. DonatoNot yet recruiting